[1]
Suresh, A.V.; Varma, P.P.; Sinha, S.; Deepika, S.; Raman, R.; Srinivasan, M.; Mandapal, T.; Reddy, C.O.; Anand, B.B. Risk-scoring system for predicting mucositis in patients of head and neck cancer receiving concurrent chemoradiotherapy [rssm-hn]. J. Cancer Res. Ther., 2010, 4, 448-451.
[2]
Pagano, L.; Caira, M.; Candoni, A.; Offidani, M.; Fianchi, L.; Martino, B.; Pastore, D.; Picardi, M.; Bonini, A.; Chierichini, A.; Fanci, R.; Caramatti, C.; Invernizzi, R.; Mattei, D.; Mitra, M.E.; Melillo, L.; Aversa, F.; Van Lint, M.T.; Falcucci, P.; Valentini, C.G.; Girmenia, C.; Nosari, A. The epidemiology of fungal infections in patients with hematologic malignancies: The SEIFEM-2004 study. Haematologica, 2006, 91, 1068-1075.
[3]
Carrigan, S.D.; Scott, G.; Tabrizian, M. Toward resolving the challenges of sepsis diagnosis. Clin. Chem., 2004, 8, 1301-1314.
[4]
Morrell, M.; Fraser, V.J.; Kollef, M.H. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob. Agents Chemother., 2005, 49, 3640-3645.
[5]
Hugonnet, S.; Sax, H.; Eggimann, P.; Chevrolet, J.C.; Pittet, D. Nosocomial bloodstream infection and clinical sepsis. Emerg. Infect. Dis., 2004, 10, 76-81.
[6]
Avolio, M.; Diamante, P.; Zamparo, S.; Modolo, M.L.; Grosso, S.; Zigante, P.; Tosoni, N.; De Rosa, R.; Stano, P.; Camporese, A. Molecular identification of bloodstream pathogens in patients presenting to the emergency department with suspected sepsis. Shock, 2010, 34, 27-30.
[7]
Lehmann, L.E.; Hunfeld, K.P.; Emrich, T.; Haberhausen, G.; Wissing, H.; Hoeft, A.; Stüber, F. A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med. Microbiol. Immunol., 2008, 197, 313-324.
[8]
von Lilienfeld-Toal, M.; Lehmann, L.E.; Raadts, A.D.; Hahn-Ast, C.; Orlopp, K.S.; Marklein, G.; Purr, I.; Cook, G.; Hoeft, A.; Glasmacher, A.; Stüber, F. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J. Clin. Microbiol., 2009, 47, 2405-2410.
[9]
Sun, Y.; Huang, H.; Chen, J.; Li, J.; Ma, J.; Li, J.; Liang, Y.; Wang, J.; Li, Y.; Yu, K.; Hu, J.; Jin, J.; Wang, C.; Wu, D.; Xiao, Y.; Huang, X. Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China. Tumour Biol., 2015, 36, 757-767.
[10]
Erjavec, Z. Kluin-Nele mans, H.; Verweij, P. E. Trends in invasive fungal infections, with emphasis on invasive aspergillosis. Clin. Microbiol. Infect., 2009, 15, 625-633.
[11]
Warnock, D.W. Trends in epidemiology of invasive fungal infections. Jpn. J. Med. Mycol, 2007, 48, 1-12.
[12]
Donhujisen, K.; Petersen, P.; Schmid, K.W. Trend reversal in the frequency of mycoses in hematological neoplasias. Dtsch. Arztebl. Int., 2008, 105, 501-506.
[13]
Ruhnke, M. Epidemiology of Candida albicans infections and role of non-Candida -albicans yeasts. Curr. Drug Targets, 2006, 7(4), 495-504.
[14]
Marr, K.A. Invasive Candida infections: the changing epidemiology. Oncology, 2004, 18, 9-14.
[15]
Marr, K.A.; Carter, R.A.; Crippa, F.; Wald, A.; Corey, L. Epidemiology and outcome of mold infections in hematopoietic stem cell transplantation recipients. Clin. Infect. Dis., 2002, 34, 909-917.
[16]
Bow, E.J.; Laverdière, M.; Lussier, N.; Rotstein, C.; Cheang, M.S.; Ioannou, S. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer, 2002, 94, 3230-3246.
[17]
Leroy, O.; Gangneux, J.P.; Montravers, P.; Mira, J.P.; Gouin, F.; Sollet, J.P.; Carlet, J.; Reynes, J.; Rosenheim, M.; Regnier, B.; Lortholary, O. AmarCand Study Group. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit. Care Med., 2009, 37, 1612-1618.
[18]
Mauro, M.V.; Cavalcanti, P.; Perugini, D.; Noto, A.; Sperlì, D.; Giraldi, C. Diagnostic utility of Light Cycler SeptiFast and procalcitonin assays in the diagnosis of bloodstream infection in immunocompromised patients. Diagn. Microbiol. Infect. Dis., 2012, 73, 308-311.
[19]
Paolucci, M.; Stanzani, M.; Melchionda, F.; Tolomelli, G.; Castellani, G.; Landini, M.P.; Varani, S.; Lewis, R.E.; Sambri, V. Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patients. Diagn. Microbiol. Infect. Dis., 2013, 75, 130-134.
[20]
Grace, C.J.; Lieberman, J.; Pierce, K.; Littenberg, B. Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy. Clin. Infect. Dis., 2001, 32, 1651-1655.
[21]
Serody, J.S.; Berrey, M.M.; Albritton, K.; O’Brien, S.M.; Capel, E.P.; Bigelow, S.H.; Weber, D.J.; Gabriel, D.A.; Wiley, J.M.; Schell, M.J.; Gilligan, P.H.; Shea, T.C. Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant., 2000, 26, 533-538.
[22]
Paolucci, M.; Stanzani, M.; Melchionda, F.; Tolomelli, G.; Castellani, G.; Landini, M.P.; Varani, S.; Lewis, R.E.; Sambri, V. Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patients. Diagn. Microbiol. Infect. Dis., 2013, 75, 130-134.
[23]
Jiang, H.H.; Zhang, H.; She, G.R.; Zhang, J.W.; Zhang, D. Historical and geography studies on deep mycosis in China since 1950 to 2007. Chin. J. Mycol. (Chin), 2010, 5, 148-153.
[24]
Martino, R.; Subira, M. Invasive fungal infections in hematology: new trends. Ann. Hematol., 2002, 81, 233-243.
[25]
Reynolds, L.; McKee, M. Factors influencing antibiotic prescribing in China: an exploratory analysis. Health Policy, 2009, 90, 32-36.
[26]
Caira, M.; Trecarichi, E.M.; Mancinelli, M.; Leone, G.; Pagano, L. Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment. Expert Rev. Anti Infect. Ther., 2011, 9, 881-892.
[27]
Rammaert, B.; Lanternier, F.; Poirée, S.; Kania, R.; Lortholary, O. Diabetes and mucormycosis: a complex interplay. Diabetes Metab., 2012, 38, 193-204.
[28]
Guinea, J.; Torres-Narbona, M.; Gijón, P.; Muñoz, P.; Pozo, F.; Peláez, T.; de Miguel, J.; Bouza, E. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin. Microbiol. Infect., 2010, 16, 870-877.
[29]
Chang, S.S.; Hsieh, W.H.; Liu, T.S.; Lee, S.H.; Wang, C.H.; Chou, H.C.; Yeo, Y.H.; Tseng, C.P.; Lee, C.C. Multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis - a systemic review and meta-analysis. PLoS One, 2013, 8, e62323.
[30]
El-Mahallawy, H.A.; Shaker, H.H.; Ali Helmy, H.; Mostafa, T. Razak, Abo-Sedah. A. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients. Med. Mycol., 2006, 44, 733-739.